• Search
  • Login
  • Register
Menu
  • Last issue
  • Home
  • News
  • CongressUpdate
  • Guidelines
  • Specials
  • Links
  • Reimbursement News
All
  • All
  • BJH articles
  • Blog articles
  • Specials
Forgot Password? Not a member yet? Register here
News > Clinical trials

Category

All
  • General
  • Healthy Living
  • Pharma News
  • Health of Tomorrow
  • Viewpoints
  • Art Corner
  • Fundraising
  • Prevention
  • Science
  • Clinical trials
  • Clinical practice
  • Corona
  • Medical Research
  • Health Innovation
  • Art on View
  • Podcasts
  • Therapy
  • Editor's pick
  • Covid-19
  • Society Announcement
  • Reimbursement News
  • Congress News

Specialty

All
  • Alle
  • YESCARTA
  • BEKEMV
  • NPLATE

Clinical trials

Add-on therapy with danicopan improves haemoglobin levels in patients with PNH

Read more
subscribe Latest issue All issues Newsletters
Index latest issue
  • INTRODUCTION
  • Advancements in thrombophilia testing: The role of multi-gene panels in venous thromboembolism
  • The role of UBTF-TD mutations in paediatric acute myeloid leukaemia and myelodysplastic syndrome
  • Desensitisation as treatment option in patients with drug hypersensitivity
  • HMB-001: Novel treatment for Glanzmann thrombasthenia
  • Anti-IL6 receptor antibody for the treatment of immune checkpoint-related hemophagocytic lymphohistiocytosis
  • Highlights from EBMT 2025
  • Journal scan
  • New haematology reimbursements in Belgium
Clinical trials

Decitabine monotherapy: A safer alternative to chemotherapy for older patients with AML

Read more
Clinical trials

Emicizumab prophylaxis effectively prevents bleeding in patients with acquired haemophilia A

Read more
Clinical trials

Adding glasdegib to chemotherapy does not improve survival in patients with untreated AML

Read more
Clinical trials

Continued support for daratumumab plus pomalidomide and dexamethasone in myeloma

Read more
Clinical trials

Belantamab mafodotin fails to delay disease progression in R/R multiple myeloma

Read more
Clinical trials

Axi-cel as an effective second-line treatment for R/R LBCL patients ineligible for transplanta...

Read more
Clinical trials

Reduced annualised bleeding rate in haemophilia patients receiving concizumab

Read more
CongressUpdate

Prognostic factors for maintenance of molecular remission after TKI discontinuation in CML pat...

Read more
Previous 1 2 3 4 5 6 7 Next
Top

Join our newsletter

  • This field is for validation purposes and should be left unchanged.
  • About BJH
  • Advertisements & sponsoring
  • Vacancies
  • Disclaimer
  • Privacy
  • Contact

BJH is published by Ariez International BV, Westzijde 22, 1506 EE Zaandam, The Netherlands

© BJH 2025